Rasagiline in treatment of Parkinson’s disease
Lakshmi Nayak1, Claire Henchcliffe21Department of Neurology; 2Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, USAAbstract: Rasagiline (N-propargyl-1 (R)-aminoindan) is a novel propargylamine, irreversible, selective monoamine oxidase inhibitor for tre...
Guardado en:
Autores principales: | Lakshmi Nayak, Claire Henchcliffe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2700160b77974365b071192318f7b89c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Adjunctive therapy in Parkinson's disease: the role of rasagiline
por: Gaines KD, et al.
Publicado: (2012) -
Current approaches to the treatment of Parkinson’s disease
por: Joseph Jankovic, et al.
Publicado: (2008) -
Update on ropinirole in the treatment of Parkinson’s disease
por: Holly A Shill, et al.
Publicado: (2008) -
Rivastigmine for the treatment of dementia associated with Parkinson’s disease
por: Jennifer L Reingold, et al.
Publicado: (2007) -
Update on the use of pramipexole in the treatment of Parkinson’s disease
por: Radu Constantinescu
Publicado: (2008)